Advancements to Explore Recent Breakthroughs in Drug Development for Emerging Diseases

Share Article

Discover how breakthroughs in science and technology are creating a new approach to preparedness.

News Image

An upcoming segment of Advancements with Ted Danson will focus on innovations in antiviral drugs for emerging diseases.

In this segment, viewers will learn how technology is accelerating interdisciplinary team science in an effort to create antiviral drugs for emerging viruses. Hearing from experts in the field, spectators will see how the Rapidly Emerging Antiviral Drug Development Initiative (READDI) is accelerating the pace of antiviral development globally for multiple virus families with the greatest pandemic potential.

“We must work together on a global scale to continue to fight COVID and prepare for the next pandemic,” said James Rosen, CEO of READDI. “READDI’s collaborative model leverages partnerships with academia, industry, government and philanthropy to accelerate development of the next generation of medicines against deadly viruses with pandemic potential.”

Audiences will learn how READDI is bringing together experts from different areas to focus on the single problem of making new antiviral drugs.

“Although new viruses emerge with ever-increasing frequency, we still lack antiviral therapeutics for the vast majority of viral diseases today,” said Tamara Phillips, senior producer for the Advancements series. “In this segment, we look forward to sharing how efforts in this area are expanding capabilities so we can be better prepared for the future.”

The Rapidly Emerging Antiviral Drug Development Initiative (READDI) is a global collaborative focused on discovering and developing broad-spectrum small molecule drugs in preparation for the inevitable next viral pandemic. READDI was launched in 2020 as a global public-private partnership. The initiative was led by three schools at the University of North Carolina at Chapel Hill – the UNC Eshelman School of Pharmacy, the UNC School of Medicine and the UNC Gillings School of Global Public Health – along with the Eshelman Institute for Innovation, which is within the UNC Eshelman School of Pharmacy, and the Structural Genomics Consortium.

For more information, visit:

About Advancements and DMG Productions:
Advancements is an information-based educational television series that explores recent developments taking place across several industries and economies. Shining a light on important issues and topics impacting society today, the series features the cutting-edge improvements, state-of-the-art technologies, and innovative solutions responsible for shaping, molding, and transforming our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming for viewers and networks.

For more information, please visit or call 866-496-4065.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah McBrayer
Visit website